Day One Biopharmaceuticals (DAWN) – Analyst Ratings
-
Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
-
TD Cowen Reiterates Buy Rating on Day One Biopharmaceuticals (DAWN)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DAWN Stock Lookup